Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357267C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
12/26/2007CN100357264C Charles ketone oxime and its composition , preparation method and uses
12/26/2007CN100356981C Ligand oligopeptide specific combining human epidermal growth factor receptor EGFR
12/26/2007CN100356979C Integrin expression inhibitors
12/26/2007CN100356945C Externally used medicine for treating skin carcinoma and its preparing process
12/26/2007CN100356920C Alkaloid liposome in vinca and production technique
12/26/2007CN100356919C Hydroxycamptothecin liposome and its preparation
12/26/2007CN100356916C Pharmaceutical compositions
12/26/2007CA2610439A1 Unit dosage forms of temozolomide
12/25/2007US7312356 Medicament
12/25/2007US7312344 Dimeric isoflavones
12/25/2007US7312341 Kinase inhibitors; rheumatic diseases; antiarthritic agents
12/25/2007US7312339 cytotoxic agents; made by fermentation of Streptomyces sparsogenes
12/25/2007US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007US7312318 treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases
12/25/2007US7312304 Somatostatin agonists
12/25/2007US7312244 For therapy of cancer, as antitumor agent
12/25/2007US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/25/2007US7312226 1-Benzo[1.3]dioxol-5-yl methyl-3-[2-(6,7-dimethoxy-quinazolin-4ylamino)-pyrimidin-5yl]-thiourea (14); anticarcinogenic, antitumor, antdiabetic, antiproliferative agent
12/25/2007US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312216 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent
12/25/2007US7312215 Anticancer agents
12/25/2007US7312213 Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312205 Methods and compositions for inhibiting tumor growth
12/25/2007US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/25/2007US7312024 Anticancer agents; administering interleukin polypeptide
12/25/2007US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy
12/21/2007WO2007146831A2 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/21/2007WO2007146796A2 Antiproliferative compounds, compositions and methods of use
12/21/2007WO2007146715A1 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
12/21/2007WO2007146602A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
12/21/2007WO2007146414A2 Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents
12/21/2007WO2007145921A1 Imidazopyrazines as protein kinase inhibitors
12/21/2007WO2007145574A1 Heat processed vegetabilic fiber preparation and its use as inhibitor of the effects of carcinogenic substances in humans or animals
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007145365A1 Therapeutic agent for cancer and method for screening for the same
12/21/2007WO2007145318A1 Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same
12/21/2007WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue
12/21/2007WO2007145227A1 Hematopoietic stem cell proliferation promoter
12/21/2007WO2007144985A1 Use of rpn2 gene expression inhibitor
12/21/2007WO2007144876A1 Methods for treating cancer
12/21/2007WO2007144730A1 Compositions and methods for delivering anti-activated ras antibodies into cells
12/21/2007WO2007144709A2 Leptomycin derivatives
12/21/2007WO2007144579A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer
12/21/2007WO2007144554A2 Gnrh (gonadotropin-releasing hormone) peptide variants
12/21/2007WO2007144423A1 Antitumoral dihydropyran-2-one compounds
12/21/2007WO2007144384A1 Pyrazolopyrimidones
12/21/2007WO2007144370A1 New chemical compounds
12/21/2007WO2007144218A1 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/21/2007WO2007144204A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007144203A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007WO2007144202A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007143917A1 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody
12/21/2007WO2007143895A1 Supersaturated solution of gemcitabine hydrochloride and prepraration method thereof
12/21/2007WO2007123939A3 Novel arylamino n-heteraryls as mek inhibitors
12/21/2007WO2007121883A3 1,4:3,6-dianhydromannitol derivatives and use thereof
12/21/2007WO2007115269A3 Orally bioavailable caffeic acid related anticancer drugs
12/21/2007WO2007113266A3 Novel compounds and methods for their production
12/21/2007WO2007106236A3 Pyrrolo-pyridine kinase modulators
12/21/2007WO2007105058A3 Pyrazole compounds
12/21/2007WO2007059359A3 Substituted pyrazalones
12/21/2007WO2007054623A3 Mammalian hedgehog signaling inhiabitors
12/21/2007WO2007053573A3 Treatment of cancer with sorafenib
12/21/2007WO2007042261A3 Compositions comprising cross-species-specific antibodies and uses thereof
12/21/2007WO2007027344A3 Compounds and methods for the treatment of cancer
12/21/2007WO2007016338A3 Use of chk2 kinase inhibitors for cancer treatment
12/21/2007CA2657951A1 Agents for promoting the growth of hematopoietic stem cells
12/21/2007CA2655411A1 Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents
12/21/2007CA2655361A1 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
12/21/2007CA2655355A1 Use of rpn2 gene expression inhibitor
12/21/2007CA2655267A1 Pyrazolopyrimidones
12/21/2007CA2654987A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654876A1 1-8-naphthyridine compounds for the treatment of cancer
12/21/2007CA2654789A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654722A1 Thiadiazole compounds and methods of use thereof
12/21/2007CA2654439A1 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
12/21/2007CA2654334A1 Antitumoral dihydropyran-2-one compounds
12/21/2007CA2654322A1 Leptomycin derivatives
12/21/2007CA2654317A1 Single-chain multivalent binding proteins with effector function
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2654212A1 New chemical compounds
12/21/2007CA2654202A1 Imidazopyrazines as protein kinase inhibitors
12/21/2007CA2654105A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007CA2653654A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
12/21/2007CA2652516A1 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/20/2007US20070293683 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293673 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293672 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293585 Gossypol co-crytals and the use thereof
12/20/2007US20070293570 Pharmaceutical uses for alpha2delta ligands
12/20/2007US20070293560 Compounds and compositions
12/20/2007US20070293557 Anticancer compositions, and methods of making and using the same
1 ... 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 ... 2211